Allergan's GI business grows by 8.2% in Q3 & more — 3 GI company key notes

Here are three updates on gastroenterology and endoscopy companies.

Despite falling revenues, Madison, N.J.-based Allergan's gastroenterology franchise grew by 8.2 percent in the third quarter.

Cambridge, Mass.-based Idera Pharmaceuticals and Bermuda-based Vivelix Pharmaceuticals entered into an exclusive license and collaboration agreement.

Genetic Technologies and Australia-based University of Melbourne have entered a license agreement to develop a new colorectal cancer risk assessment test.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers

Featured Podcast